BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 7640945)

  • 1. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI
    Gastroenterologist; 1995 Jun; 3(2):141-52. PubMed ID: 7640945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ
    Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA
    Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?
    Sands BE
    Gut; 2006 Apr; 55(4):437-41. PubMed ID: 16531519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
    Aranda R; Horgan K
    Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive therapy of inflammatory diseases of the large intestine].
    Rumiantsev VG; Rogozina VA; Osina VA
    Eksp Klin Gastroenterol; 2004; (6):89-98, 165. PubMed ID: 16259448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive drugs in Crohn's disease.
    Kornbluth A; George J; Sachar DB
    Gastroenterologist; 1994 Sep; 2(3):239-46. PubMed ID: 7987622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate: first-line or second-line immunomodulator?
    Fraser AG
    Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):225-31. PubMed ID: 12610315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ
    Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
    [No Abstract]   [Full Text] [Related]  

  • 16. A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at the Mount Sinai Hospital.
    Korelitz BI; Present DH
    Mt Sinai J Med; 1996; 63(3-4):191-201. PubMed ID: 8692165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Azathioprine, 6-mercaptopurine, and inflammatory diseases of the intestine].
    Beaugerie L; Gendre JP
    Gastroenterol Clin Biol; 1990; 14(3):230-40. PubMed ID: 2188863
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerability and safety of mercaptopurine in azathioprine-intolerant patients with inflammatory bowel disease.
    Lees CW; Maan AK; Hansoti B; Satsangi J; Arnott ID
    Aliment Pharmacol Ther; 2008 Feb; 27(3):220-7. PubMed ID: 17988235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T; Iwao Y; Yajima T; Inoue N; Ueno Y; Takaishi H; Watanabe M; Ishii H
    J Gastroenterol; 1995 Nov; 30 Suppl 8():121-3. PubMed ID: 8563872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine and other immunosuppressive agents: current and future role in the treatment of inflammatory bowel disease.
    Present DH
    Am J Gastroenterol; 1993 May; 88(5):627-30. PubMed ID: 8480721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.